Silverfin false false 30/04/2024 01/05/2023 30/04/2024 Y Kabagabo 12/07/2024 P Schnatterbeck 10/04/2007 03 February 2025 The principal activity of the company continued to be that of providing medical services. 06207816 2024-04-30 06207816 bus:Director1 2024-04-30 06207816 bus:Director2 2024-04-30 06207816 2023-04-30 06207816 core:CurrentFinancialInstruments 2024-04-30 06207816 core:CurrentFinancialInstruments 2023-04-30 06207816 core:ShareCapital 2024-04-30 06207816 core:ShareCapital 2023-04-30 06207816 core:RetainedEarningsAccumulatedLosses 2024-04-30 06207816 core:RetainedEarningsAccumulatedLosses 2023-04-30 06207816 core:ComputerEquipment 2023-04-30 06207816 core:ComputerEquipment 2024-04-30 06207816 bus:OrdinaryShareClass1 2024-04-30 06207816 2023-05-01 2024-04-30 06207816 bus:FilletedAccounts 2023-05-01 2024-04-30 06207816 bus:SmallEntities 2023-05-01 2024-04-30 06207816 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 06207816 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 06207816 bus:Director1 2023-05-01 2024-04-30 06207816 bus:Director2 2023-05-01 2024-04-30 06207816 core:ComputerEquipment core:TopRangeValue 2023-05-01 2024-04-30 06207816 2022-05-01 2023-04-30 06207816 core:ComputerEquipment 2023-05-01 2024-04-30 06207816 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 06207816 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 06207816 (England and Wales)

SCHNATTERBECK MEDICAL SERVICES LTD

Unaudited Financial Statements
For the financial year ended 30 April 2024
Pages for filing with the registrar

SCHNATTERBECK MEDICAL SERVICES LTD

Unaudited Financial Statements

For the financial year ended 30 April 2024

Contents

SCHNATTERBECK MEDICAL SERVICES LTD

BALANCE SHEET

As at 30 April 2024
SCHNATTERBECK MEDICAL SERVICES LTD

BALANCE SHEET (continued)

As at 30 April 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 2,566 4,462
2,566 4,462
Current assets
Debtors 4 0 11,523
Cash at bank and in hand 169,737 127,570
169,737 139,093
Creditors: amounts falling due within one year 5 ( 34,515) ( 54,665)
Net current assets 135,222 84,428
Total assets less current liabilities 137,788 88,890
Provision for liabilities ( 604) ( 1,115)
Net assets 137,184 87,775
Capital and reserves
Called-up share capital 6 100 100
Profit and loss account 137,084 87,675
Total shareholders' funds 137,184 87,775

For the financial year ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Schnatterbeck Medical Services Ltd (registered number: 06207816) were approved and authorised for issue by the Board of Directors on 03 February 2025. They were signed on its behalf by:

P Schnatterbeck
Director
SCHNATTERBECK MEDICAL SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
SCHNATTERBECK MEDICAL SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Schnatterbeck Medical Services Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2 Leman Street, London, E1W 9US, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 2 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 3 4

3. Tangible assets

Computer equipment Total
£ £
Cost
At 01 May 2023 6,609 6,609
Additions 948 948
At 30 April 2024 7,557 7,557
Accumulated depreciation
At 01 May 2023 2,147 2,147
Charge for the financial year 2,844 2,844
At 30 April 2024 4,991 4,991
Net book value
At 30 April 2024 2,566 2,566
At 30 April 2023 4,462 4,462

4. Debtors

2024 2023
£ £
Other debtors 0 11,523

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 1,920 0
Taxation and social security 30,562 21,207
Other creditors 2,033 33,458
34,515 54,665

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100